We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J Sees Delays in Coronavirus Vaccine Production as It Approaches Regulatory Finish Line
J&J Sees Delays in Coronavirus Vaccine Production as It Approaches Regulatory Finish Line
As Johnson & Johnson (J&J) nears the release of critical phase 3 trial results and potential emergency authorization for its promising COVID-19 vaccine, the company has reportedly hit speedbumps in manufacturing doses.